Coronary microvascular dysfunction (CMD) is common in patients with non-obstructive coronary arteries but has not been described in low-risk symptomatic patients. We therefore assessed the prevalence and characteristics of CMD in low to moderate risk patients with chest pain in an emergency department.
Methods and results:
We used three-dimensional Rb82 cardiac positron emission tomography/computed tomography to diagnose coronary artery disease (known or new regional defect, any coronary calcification) and CMD (low coronary flow reserve without coronary artery disease) in chest pain patients after being ruled out for acute myocardial infarction. Exclusions included age 30 years or less, acute myocardial infarction, hemodynamic instability, heart failure and dialysis. Among 195 participants undergoing cardiac positron emission tomography/computed tomography, 42% had CMD, 36% had coronary artery disease and 22% had normal flows; 70% were women and 84% were obese. Patients with CMD and coronary artery disease had significantly lower coronary flow reserve than normal patients (mean coronary flow reserve 1.6 and 1.9 vs. 2.6, respectively, P<0.05). However, CMD patients were younger (mean age 51 vs. 61 years), and had fewer traditional cardiac risk factors (P<0.05) than patients with coronary artery disease. Nearly one third (31%) of patients had a prior emergency department visit for chest pain within three years of index presentation. Women were four times as likely to have CMD as men (adjusted odds ratio 4.2; 95% confidence interval 1.8, 9.6) after controlling for age, race, hypertension, diabetes, smoking, dyslipidemia, obesity and family history of coronary artery disease.
Conclusions:
Despite their low-risk profile, nearly one half of symptomatic and mostly obese emergency department patients without evidence of myocardial infarction or coronary artery disease had CMD. The results could explain the high rates of return visits associated with chest pain, although their application to the general emergency department population require validation.
SelkerHPBeshanskyJRGriffithJL, et al. Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial. Ann Intern Med1998; 129: 845–855.
3.
SafdarBD’OnofrioG.Women and chest pain: recognizing the different faces of angina in the emergency department. Yale J Biol Med2016; 89: 227–238.
RadicoFCicchittiVZimarinoM, et al. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC Cardiovasc Interv2014; 7: 453–463.
6.
LeeBKLimHSFearonWF, et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation2015; 131: 1054–1060.
7.
ShawLJMerzCNPepineCJ, et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health – National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation. Circulation2006; 114: 894–904.
8.
BugiardiniRBairey MerzCN and author reply. Angina with “normal” coronary arteries: a changing philosophy. JAMA: the journal of the American Medical Association2005; 293: 477–484.
9.
GulatiMCooper-DeHoffRMMcClureC, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med2009; 169: 843–850.
10.
JespersenLHvelplundAAbildstromSZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J2012; 33: 734–744.
11.
SedlakTLLeeMIzadnegahdarM, et al. Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. Am Heart J2013; 166: 38–44.
12.
Bairey MerzCNPepineCJWalshMN, et al. Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation2017; 135: 1075–1092.
13.
HerzogBAHusmannLValentaI, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol2009; 54: 150–156.
14.
MurthyVLNayaMFosterCR, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation2012; 126: 1858–1868.
15.
PepineCJAndersonRDSharafBL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol2010; 55: 2825–2832.
16.
DeWoodMASporesJNotskeR, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med1980; 303: 897–902.
17.
PollackCVJrSitesFDShoferFS, et al. Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. Acad Emerg Med2006; 13: 13–18.
18.
HellerGVBeanlandsRMerlinoDA, et al. ASNC model coverage policy: cardiac positron emission tomographic imaging. J Nucl Cardiol2013; 20: 916–947.
19.
NesterovSVDeshayesESciagraR, et al. Quantification of myocardial blood flow in absolute terms using (82)Rb PET imaging: the RUBY-10 Study. JACC Cardiovasc Imag2014; 7: 1119–1127.
20.
OngPCamiciPGBeltrameJF, et al.; and the Coronary Vasomotion Disorders International Study Group. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol2018; 250: 16–20.
21.
SafdarBDziuraJBathulapalliH, et al. Chest pain syndromes are associated with high rates of recidivism and costs in young United States Veterans. BMC Fam Pract2015; 16: 88.
22.
RobertsonNJavedNSamaniNJ, et al. Psychological morbidity and illness appraisals of patients with cardiac and non-cardiac chest pain attending a rapid access chest pain clinic: a longitudinal cohort study. Heart2008; 94: e12.
23.
SaraJDWidmerRJMatsuzawaY, et al. Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc Interv2015; 8: 1445–1453.
24.
ReisSEHolubkovRConrad SmithAJ, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J2001; 141: 735–741.
25.
OngPAthanasiadisAHillS, et al. Coronary microvascular dysfunction assessed by intracoronary acetylcholine provocation testing is a frequent cause of ischemia and angina in patients with exercise-induced electrocardiographic changes and unobstructed coronary arteries. Clin Cardiol2014; 37: 462–467.
26.
MurthyVLNayaMFosterCR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation2011; 124: 2215–2224.
27.
FukushimaKJavadiMSHiguchiT, et al. Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. J Nucl Med2011; 52: 726–732.
28.
MurthyVLNayaMTaquetiVR, et al. Effects of gender on coronary microvascular dysfunction andcardiac outcomes. Circulation2014; 129: 2518–2527.
MarinescuMALofflerAIOuelletteM, et al. Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC Cardiovasc Imag2015; 8: 210–220.
31.
RussoGDi FrancoALamendolaP, et al. Lack of effect of nitrates on exercise stress test results in patients with microvascular angina. Cardiovasc Drugs Ther: sponsored by the International Society of Cardiovascular Pharmacotherapy2013; 27: 229–234.
32.
BugiardiniRBorghiAPozzatiA, et al. The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries. Am J Cardiol1993; 72: 343–347.
33.
KanatsukaHEasthamCLMarcusML, et al. Effects of nitroglycerin on the coronary microcirculation in normal and ischemic myocardium. J Cardiovasc Pharmacol1992; 19: 755–763.
34.
PaulyDFJohnsonBDAndersonRD, et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J2011; 162: 678–684.
35.
SafdarBD’OnofrioGDziuraJ, et al. Ranolazine and microvascular angina by PET in the emergency department: results from a pilot randomized controlled trial. Clin Ther2017; 39: 55–63.
36.
AbularrageCJSidawyANAidinianG, et al. Evaluation of the microcirculation in vascular disease. J Vasc Surg2005; 42: 574–581.
OhbaKSugiyamaSSumidaH, et al. Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease. J Am Heart Assoc2012; 1: e002485.
SuzukiHMatsubaraHKobaS, et al. Clinical characteristics and follow-up in patients with microvascular angina. Circ J2002; 66: 691–695.
41.
BugiardiniRManfriniOPizziC, et al. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation2004; 109: 2518–2523.
42.
SpatzESCurryLAMasoudiFA, et al. The VIRGO Classification System: a taxonomy for young women with acute myocardial infarction. Circulation2015; 132: 1710–1718.
43.
GerminoMRopchanJMulnixT, et al. Quantification of myocardial blood flow with (82)Rb: validation with (15)O-water using time-of-flight and point-spread-function modeling. EJNMMI Res2016; 6: 68.
LeschkaSStinnBSchmidF, et al. Dual source CT coronary angiography in severely obese patients: trading off temporal resolution and image noise. Invest Radiol2009; 44: 720–727.
46.
de Araujo GoncalvesPJeronimo SousaPCaleR, et al. Effective radiation dose of three diagnostic tests in cardiology: single photon emission computed tomography, invasive coronary angiography and cardiac computed tomography angiography. Rev Port Cardiol2013; 32: 981–986.
47.
TaquetiVRDorbalaSWolinskyD, et al. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease – state-of-the-evidence and clinical recommendations. J Nucl Cardiol2017; 24: 1402–1426.
48.
YuYChanCMaT, et al. Event-by-event continuous respiratory motion correction for dynamic PET imaging. J Nucl Med2016; 57: 1084–1090.
49.
ThygesenKAlpertJSJaffeAS, et al.; and Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Glob Heart2012; 7: 275–295.
50.
ShahASMcAllisterDAMillsR, et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med2015; 128: 493–501.e3.
51.
WhiteHD.Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?J Am Coll Cardiol2011; 57: 2406–2408.
52.
PasupathySTavellaRBeltrameJF.Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): the past, present, and future management. Circulation2017; 135: 1490–1493.
53.
CamiciPGCreaF.Coronary microvascular dysfunction. N Engl J Med2007; 356: 830–840.
54.
SchindlerTHNitzscheEUSchelbertHR, et al. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol2005; 45: 1505–1512.
55.
KaufmannPACamiciPG.Myocardial blood flow measurement by PET: technical aspects and clinical applications. J Nucl Med2005; 46: 75–88.
56.
SafdarBAliAD’OnofrioG, et al. Microvascular dysfunction as opposed to conduit artery disease explains sex-specific chest pain in emergency department patients with low to moderate cardiac risk. Clin Ther2016; 38: 240–255.e1.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
